AVR vs CLOV · rev $429.0K vs rev $1.37B
Anteris Technologies Global Corp. Common Stock (AVR) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AVR revenue for 2025-09-30 was $429.0K. Net income was -$22.2M. Revenue was down 30.6% from 2025-06-30 to 2025-09-30. AVR currently screens at market cap $287.2M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AVR currently screens at market cap $287.2M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AVR and CLOV stock pages for the full models.
Not investment advice.